Suppr超能文献

DNA错配修复蛋白MLH1和MSH2在人结肠癌细胞系凋亡中的相互依赖性。

Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.

作者信息

Hassen Samar, Ali Akhtar A, Kilaparty Surya P, Al-Anbaky Qudes A, Majeed Waqar, Boman Bruce M, Fields Jeremy Z, Ali Nawab

机构信息

Department of Biology, College of Arts, Letters and Sciences, University of Arkansas at Little Rock, 2801 S. University Avenue, Little Rock, AR, 72204, USA.

CATX Inc., Gladwyne, PA, 19035, USA.

出版信息

Mol Cell Biochem. 2016 Jan;412(1-2):297-305. doi: 10.1007/s11010-015-2636-3. Epub 2016 Jan 4.

Abstract

The mammalian DNA mismatch repair (MMR) system consists of a number of proteins that play important roles in repair of base pair mismatch mutations and in maintenance of genomic integrity. A defect in this system can cause genetic instability, which can lead to carcinogenesis. For instance, a germline mutation in one of the mismatch repair proteins, especially MLH1 or MSH2, is responsible for hereditary non-polyposis colorectal cancer. These MMR proteins also play an important role in the induction of apoptosis. Accordingly, altered expression of or a defect in MLH1 or MSH2 may confer resistance to anti-cancer drugs used in chemotherapy. We hypothesized that the ability of these two MMR proteins to regulate apoptosis are interdependent. Moreover, a defect in either one may confer resistance to chemotherapy by an inability to trigger apoptosis. To this end, we studied three cell lines-SW480, LoVo, and HTC116. These cell lines were selected based on their differential expression of MLH1 and MSH2 proteins. SW480 expresses both MLH1 and MSH2; LoVo expresses only MLH1 but not MSH2; HCT116 expresses only MSH2 but not MLH1 protein. MTT assays, a measure of cytotoxicity, showed that there were different cytotoxic effects of an anti-cancer drug, etoposide, on these cell lines, effects that were correlated with the MMR status of the cells. Cells that are deficient in MLH1 protein (HCT116 cells) were resistant to the drug. Cells that express both MLH1 and MSH2 proteins (SW480 cells) showed caspase-3 cleavage, an indicator of apoptosis. Cells that lack MLH1 (HCT116 cells) did not show any caspase-3 cleavage. Expression of full-length MLH1 protein was decreased in MMR proficient (SW480) cells during apoptosis; it remained unchanged in cells that lack MSH2 (LoVo cells). The expression of MSH2 protein remained unchanged during apoptosis both in MMR proficient (SW480) and deficient (HCT116) cells. Studies on translocation of MLH1 protein from nucleus to cytosolic fraction, an indicator of apoptosis, showed that MLH1 translocation only occurred in MMR proficient (SW480) cells upon induction of apoptosis further suggested a MSH2 dependent role of MLH1 in apoptosis. These data suggest a role of MLH1 in mediation of apoptosis in a MSH2-dependent manner. Taken together, our data supported an interdependence of mismatch repair proteins, particularly MLH1 and MSH2, in the mediation of apoptosis in human colorectal carcinoma cell lines.

摘要

哺乳动物DNA错配修复(MMR)系统由多种蛋白质组成,这些蛋白质在碱基对错配突变的修复以及基因组完整性的维持中发挥着重要作用。该系统的缺陷会导致基因不稳定,进而引发癌变。例如,错配修复蛋白之一,尤其是MLH1或MSH2中的种系突变,是遗传性非息肉病性结直肠癌的病因。这些MMR蛋白在细胞凋亡的诱导中也起着重要作用。因此,MLH1或MSH2表达的改变或缺陷可能会使细胞对化疗中使用的抗癌药物产生耐药性。我们推测这两种MMR蛋白调节细胞凋亡的能力是相互依赖的。此外,其中任何一种蛋白的缺陷都可能因无法触发细胞凋亡而导致对化疗的耐药性。为此,我们研究了三种细胞系——SW480、LoVo和HTC116。这些细胞系是根据它们MLH1和MSH2蛋白的差异表达来选择的。SW480同时表达MLH1和MSH2;LoVo仅表达MLH1而不表达MSH2;HCT116仅表达MSH2而不表达MLH1蛋白。MTT法(一种细胞毒性检测方法)显示,抗癌药物依托泊苷对这些细胞系有不同的细胞毒性作用,这些作用与细胞的MMR状态相关。缺乏MLH1蛋白的细胞(HCT116细胞)对该药物耐药。同时表达MLH1和MSH2蛋白的细胞(SW480细胞)出现了caspase-3裂解,这是细胞凋亡的一个指标。缺乏MLH1的细胞(HCT116细胞)未出现任何caspase-3裂解。在细胞凋亡过程中,MMR功能正常的(SW480)细胞中全长MLH1蛋白的表达降低;在缺乏MSH2的细胞(LoVo细胞)中其表达保持不变。在MMR功能正常的(SW480)和缺陷的(HCT116)细胞中,MSH2蛋白的表达在细胞凋亡过程中均保持不变。关于MLH1蛋白从细胞核向细胞质部分转位(细胞凋亡的一个指标)的研究表明,MLH1转位仅在诱导细胞凋亡时发生在MMR功能正常的(SW480)细胞中,这进一步表明MLH1在细胞凋亡中具有依赖MSH2的作用。这些数据表明MLH1以依赖MSH2的方式介导细胞凋亡。综上所述,我们的数据支持错配修复蛋白,特别是MLH1和MSH2,在人结肠癌细胞系细胞凋亡介导过程中的相互依赖性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验